Gilwan Kim is a health outcomes researcher with over 10 years of experience in life sciences consulting. Currently serving as a Senior Research Advisor at Eli Lilly and Company, they lead HEOR strategy development for various neurological assets. Previously, Kim worked at IBM Watson Health, where they executed real-world evidence projects and managed a team of analysts. Their academic background includes a Doctor of Pharmacy from Purdue University and a Master's degree in Health Outcomes and Pharmacy Practice from The University of Texas at Austin. Kim's expertise lies in translating data insights into health innovations.
This person is not in the org chart
This person is not in any teams
This person is not in any offices